Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine nerve block for mandibular fracture pain
NCT06243263Phase 4Recruiting
- Sponsor
- University of Tunis El Manar
- Start
- Feb 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine in postoperative pain, sponsored by University of Tunis El Manar. Started Feb 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06243263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06243263.